Selexipag + Deferasirox Interaction
Moderateinteraction on record
Description
Moderate CYP2C8 inhibitor that increases exposure to selexipag's active metabolite. Reduce selexipag dosing to once daily.
Mechanism
CYP2C8 inhibition
Source: NLP:selexipag